Peyton High

5PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 08, 2026
Antibody-drug conjugate combination therapy targeting LGR5 and MET with different payloads enhances efficacy in preclinical colorectal cancer models.

|Sep 23, 2026
Advances in Bispecific Antibodies and Antibody-Drug Conjugates for Colorectal Cancer Treatment.

|Dec 18, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Antitumor Activity in Colorectal Cancer.

Joan Jacob, Yasuaki Anami, Peyton C High

|Nov 28, 2024
Antibody-Drug Conjugates Targeting the EGFR Ligand Epiregulin Elicit Robust Anti-Tumor Activity in Colorectal Cancer.

Joan Jacob, Yasuaki Anami, Peyton High

|Jul 27, 2024
The Evolving Paradigm of Antibody-Drug Conjugates Targeting the ErbB/HER Family of Receptor Tyrosine Kinases.

Peyton High, Cara Guernsey, Shraddha Subramanian

Pageof 1

Frequent Collaborators

5 joint publications

Kendra S Carmon

4 joint publications

Shraddha Subramanian

3 joint publications

Joan Jacob

3 joint publications

Cara Guernsey-Biddle